Human Probable ATP-dependent RNA helicase DDX17 225-233, YLLPAIVHI
Description
About Human Probable ATP-dependent RNA helicase DDX17 225-233, YLLPAIVHI
The Human Probable protein ATP-dependent RNA helicase DDX17 Peptide (IEDB: 74794) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Probable protein Peptide, H-YLLPAIVHI-OH (Uniprot: Q92841 aa: 225-233) from JPT is produced under strict quality control and quality management.
Human Probable ATP-dependent RNA helicase DDX17 225-233, YLLPAIVHI - Specifications
- Peptide sequence: H-YLLPAIVHI-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Leukemia
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human Probable ATP-dependent RNA helicase DDX17 225-233, YLLPAIVHI
References:
Read References with JPT’s Antigen Peptides
Human Probable ATP-dependent RNA helicase DDX17 225-233, YLLPAIVHI has been described in:
Investigation of peptide involvement in T cell allorecognition using recombinant HLA class I multimers., J Immunol, 2005 (PMID: 16034111)
Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease Diagnosis., PLoS One, 2015 (PMID: 26492414)
Non-terminally exhausted tumor-resident memory HBV-specific T cell responses correlate with relapse-free survival in hepatocellular carcinoma., Immunity, 2021 (PMID: 34270940)
Documentation
Documentation for Human Probable ATP-dependent RNA helicase DDX17 225-233, YLLPAIVHI
Properties
Properties of Human Probable ATP-dependent RNA helicase DDX17 225-233, YLLPAIVHI
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Leukemia |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Protein Name: | Probable protein |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human Probable ATP-dependent RNA helicase DDX17 225-233, YLLPAIVHI
Information | Values |
---|---|
Sequence: | H-YLLPAIVHI-OH |
Specifications: | 9mer peptide as TFA salt |